Cyril Deceneux

RMIT University — Australia

Medicine · Health Sciences

7h-index161citations29works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(17), Protein Degradation and Inhibitors(16), Peptidase Inhibition and Analysis(14), Immunotherapy and Immune Responses(8), Click Chemistry and Applications(4)

Publications29 total

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial
Nature Communications·2025· 1 citedOpen Access
Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial
Nutrients·2024· 4 citedOpen Access
Supplementary Table S5 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Figures from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S2 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S6 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S4 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S3 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S2 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S1 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S5 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Figure and Table Legends from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Figure and Table Legends from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Data from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Data from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S3 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Figures from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S6 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S4 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
Supplementary Table S1 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Andreas Behren(22), Katherine Woods(21), Simone Ostrouska(21), Jonathan Cebon(21), Pouya Faridi(20), Ritchlynn Aranha(20), Divya Duscharla(20), Stephen Q. Wong(20), Weisan Chen(20), Sri H. Ramarathinam(20), Terry C.C. Lim Kam Sian(20), Nathan P. Croft(20), Chen Li(20), Rochelle Ayala(20), Anthony W. Purcell(20), Ralf B. Schittenhelm(20), Magdalena Plebanski(6), Georgia Goodchild(4), Jennifer C. Boer(3), Zeinab G. Khalil(3)